(Q33364319)

26 July 2017

title

Rituximab plus gemcitabine: a therapeutic option for elderly or frail patients with aggressive non Hodgkin's lymphoma? (English)

1 reference

26 July 2017

1 reference

C Wenger

1

1 reference

26 July 2017

M Stern

2

1 reference

26 July 2017

R Herrmann

3

1 reference

26 July 2017

Ch Rochlitz

4

1 reference

26 July 2017

M Pless

5

1 reference

26 July 2017

publication date

1 January 2005

1 reference

26 July 2017

1 reference

26 July 2017

volume

46

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

71-75

1 reference

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190400007540

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400007540

Rituximab-mediated sensitization of B-non-Hodgkin's lymphoma (NHL) to cytotoxicity induced by paclitaxel, gemcitabine, and vinorelbine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400007540

The Influence of advanced age on the treatment and prognosis of diffuse large-cell lymphoma (DLCL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400007540

The impact of age on delivered dose intensity and hospitalizations for febrile neutropenia in patients with intermediate-grade non-Hodgkin's lymphoma receiving initial CHOP chemotherapy: a risk factor analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400007540

Gemcitabine for relapsed or resistant lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400007540

Rituximab in combination with CHOP or fludarabine in low-grade lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400007540

10.1080/10428190400007540

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference